Global Biomaterials Market - Analysis and Forecast (2017 to 2021): Focus on Type (Polymer, metal, Ceramic, Natural, Regenerative); Application (Cardiovascular, Orthopedic, Ophthalmology, Dental, Wound Healing, Plastic Surgery, Neurological, Tissue Engineering) and Region)
The global biomaterials market in terms of value is estimated to witness growth at a CAGR of 16.0% between 2017 and 2021. The increasing demand and the growth rate for biomaterials in the market is attributed to their growing usage in applications of cardiovascular orthopedic, ophthalmology, dental, wound healing, plastic surgery, neurological/central nervous system (CNS), and tissue engineering, among others, in the biomedical end-use industry.
The rising demand is in line with the unique properties and the biocompatabilty of biomaterials. The properties such as high strength, stiffness, corrosion resistance, fatigue strength, biofunctionality, and bioactivity make the biomaterials a preferred choice in the aforementioned applications.
The report is a compilation of various segmentations including market breakdown by biomaterial type, sub-type, end-use applications, and different geographical regions. It also includes sections on competitive insights and market dynamics. Herein, the revenue generated from the biomaterials market is tracked to calculate the market size.
While highlighting the key driving and restraining forces for this market, the report also provides a comprehensive section of the application areas of the biomaterials market. It also examines the role of the leading market players involved in this market.
The report addresses the following key questions about the global biomaterials market:
- What is the global biomaterials market size in terms of revenue from 2016-2021?
- Which is the dominant type by revenue in the biomaterials market?
- What is the revenue generated by the different biomaterials by type in the biomaterials market?
- What is the revenue generated by the different applications of the biomaterials market?
- What are the different factors driving the market in the forecast period?
- What are the major factors challenging the growth of the global biomaterials market?
- What are the opportunities for the global biomaterials market?
- What are the key future trends for the global biomaterials market?
- What kind of new strategies are being adopted by the existing market players to make a mark in the industry?
- What is the revenue generated by the different geographic regions in the biomaterials market?
- Which region will lead the global biomaterials market by the end of the forecast period?
- Which are the existing key market players that have made a mark in the biomaterials market?
The report has put special emphasis on the market share of the type and applications of the biomaterials, globally. The industry analyses have also been undertaken in order to examine the impact of various factors and understand the overall attractiveness of the industry.
The most often used strategy for developing a better hold on to the market has been through agreements, collaborations, contracts, and partnerships, followed by new product launches. The company profile section includes highlights of significant information about the key companies involved, along with their financial summaries and key strategies & developmental activities of recent years.
Some of the key players in the biomaterials market are BASF, BBS, Berkley Advanced Biomaterial Inc., Bioretec Ltd., CAM Bioceramics, Carpenter Technology Corporation, Celanese Corp., Collagen Solutions, Corbion, Covestro, Royal DSM, Evonik Industries, Invibio, Straumann, and Zimmer Biomet. These companies provide a broad product portfolio for specific needs and industrial applications.
Metal based biomaterials dominated the global biomaterials market with a share of approximately 24% in 2016. The cardiovascular application dominated the biomaterials market on the basis of application with a market share of 34% in 2016. On the basis of geography, North America dominated the biomaterials market with a market share of 42%, followed by Europe and Asia Pacific. Additionally, APAC has the highest potential to grow in the forecast period due to the presence of emerging economies such as China and India.
1 Scope and Research Methodology
1.1 Report Scope
1.2 Global Biomaterials Market Research Methodology
1.2.1 Assumptions and Limitations
1.2.2 Primary Research
1.2.3 Secondary Research
1.2.4 Data Triangulation
1.2.5 Data Analyzing and Market Estimation
2 Market Dynamics
2.1 Market Drivers
2.1.1 Increasing Funds/ Aids by the Government For Research Purposes
2.1.2 Increasing Plastic Surgery and Wound Healing Therapies
2.1.3 Increasing Aging/Geriatric Population
2.1.4 Rise in Prevalence of Cardiovascular Diseases
2.1.5 Increasing Orthopaedic Disorders
2.1.6 Growing Demand for Implantable Devices
2.1.7 Increasing Awareness of Regenerative Medicine
2.2 Market Restraints/Challenges
2.2.1 Biocompatibility Issues and Safety and Stringent Regulations
2.2.2 Limitations of Biomaterial-Based Products
2.3 Market Opportunities
2.3.1 Increasing Obesity
2.3.2 Patient Awareness and Improved Lifestyle in Emerging Economies
2.3.3 Introduction of Biomaterials in Cancer Research
2.4 Key Trends in the Biomaterials Market
3 Competitive Insights
3.1 Competitive Analysis
3.1.1 Biomaterials Market Competitive Analysis
3.2 Opportunity Matrix Analysis
3.3 Country Share Analysis
3.4 Biomaterials in Research & Development
3.5 R&D Analysis of Key Market Players
3.6 Key Strategies and Developments
3.6.1 Agreements, Collaborations, Contracts, Joint Venture, & Partnerships
3.6.2 Business Expansions
3.6.3 New Product Launches & Developments
3.6.4 Mergers & Acquisitions
4 Industry Analysis
4.1 Supply Chain Analysis
4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants
4.2.2 Threat of Substitutes
4.2.3 Bargaining Power of Buyers
4.2.4 Bargaining Power of Suppliers
4.2.5 Intensity of Competitive Rivalry
4.3 Future Trends and Developments in Biomaterials Market
5 Global Biomaterials Market, by Type
5.1.1 Stainless Steel
5.1.2 Titanium and Titanium alloys
5.1.3 Co-Cr Alloys
5.1.8 Other Metal Based Biomaterials
5.2 Polymer Based Biomaterials
5.2.1 Polyethylene Terephthalate (PET)
5.2.2 Polypropylene (PP)
5.2.3 Polyetheretherketone (PEEK)
5.2.4 Ultra-High Molecular Weight Polyethylene (UHMWPE)
5.2.5 Polytetrafluoroethylene (PTFE)
5.2.6 Polyglycolide (PGA)
5.2.7 Polyactide (PLA)
5.2.8 Polycaprolactone (PCL)
5.2.9 Polyglycerol Sebacate (PGS)
5.2.10 Polyvinylchloride (PVC)
5.2.11 Silicone Rubber
5.2.13 Polymethyl Methacrylate (PMMA)
5.2.14 Other Polymers
5.3 Ceramic Based Biomaterials
5.3.2 Calcium Phosphate
5.3.4 Calcium Sulphate
5.3.6 Other Ceramic Based Biomaterials
5.4 Natural Based Biomaterials
5.4.6 Hyaluronic Acid
5.5 Inorganic Glass Based Biomaterials
5.5.2 Bioactive Glass
5.6 Radiopaque Biomaterials
5.7 Regenerative Biomaterials
5.8 Hybrid Biomaterial Combinations
6 Global Biomaterials Market, by Application
6.1.3 Heart Valves
6.1.7 Implantable Cardiac Defibrillators
6.1.8 Vascular Grafts
6.2.1 Joint Replacement
188.8.131.52 Hip Replacements
184.108.40.206 Knee Replacements
220.127.116.11 Shoulder Replacements
18.104.22.168 Other Replacements
6.2.3 Bioresorbable Tissue Fixation
22.214.171.124 Suture Anchors
126.96.36.199 Interference Screws
188.8.131.52 Minimally Invasive Fusion Surgeries
184.108.40.206 Motion Preservation and Dynamic Stabilization
220.127.116.11.1 Pedicle Based Rod Systems
18.104.22.168.2 Interspinous Spacers
22.214.171.124.3 Disc Arthoplasty/Replacement
6.2.5 Fracture Fixation
126.96.36.199 Bone Plates
188.8.131.52 Bone Grafts
6.3.1 Contact Lenses
6.3.2 Intraocular Lenses
6.3.3 Functional Replacement of Ocular Tissues
6.3.4 Synthetic Corneas
6.4.1 Dental Bone Grafts and Substitutes
6.4.2 Dental Membranes
6.5 Wound Healing
6.5.1 Wound Closure Devices
6.5.4 Surgical Haemostats
6.5.5 Internatal Tissue Sealants
6.5.6 Adhesion Barriers
6.5.7 Hernia Meshes
6.6 Plastic Surgery
6.6.1 Soft-Tissue Fillers
6.6.2 Craniofacial Surgery
6.7 Neurological/Central Nervous System
6.7.1 Shunting Systems
6.7.2 Cortical Neural Prosthetics (CNP)
6.7.3 Hydrogel Scaffolds for CNS Report
6.7.4 Neural Stem Cell Encapsulation
6.8 Tissue Engineering
6.8.1 Scaffolds for Regenerative Medicine
6.8.2 Nanomaterial for Biosensing
6.8.3 Tailoring of Inorganic Nanoparticles
6.9.1 Drug Delivery Systems
6.9.2 Gastrointestinal Applications
6.9.3 Bariatric Surgery
6.9.4 Urinary Applications
7 Global Biomaterials Market, by Region
7.1 North America
7.1.1 Biomaterials Market, by Type
7.1.2 Biomaterials Market, by Application
7.1.3 Biomaterials Market, by Country
184.108.40.206 The U.S.
220.127.116.11.1 Biomaterials-Based Research in the U.S
18.104.22.168.2 Growing Demand for Plastic Surgeries in the U.S.
22.214.171.124.3 Conferences and Symposiums on Biomaterials in the U.S.
126.96.36.199.4 Increase in Cancer Incidence
188.8.131.52.5 Growing Prevalence of Cardiovascular Diseases
184.108.40.206.6 Regulations in the U.S.
220.127.116.11.1 Growth in the Aging Population
18.104.22.168.2 Growing Development Activities for Biomaterials in Canada
22.214.171.124.1 Growing R&D activity for Biomaterials in Mexico
126.96.36.199.2 Emergence of Dental Growth
7.2.1 Biomaterials Market, by Type
7.2.2 Biomaterials Market, by Application
7.2.3 Biomaterials Market, by Country
188.8.131.52 The U.K.
184.108.40.206 Rest of Europe(RoE)
7.3 Asia Pacific
7.3.1 Biomaterials Market, by Type
7.3.2 Biomaterials Market, by Application
7.3.3 Biomaterials Market, by Country
220.127.116.11 South Korea
18.104.22.168 Rest of Asia Pacific
7.4 Middle East & Africa
7.4.1 Biomaterials Market, by Type
7.5 South America
7.5.1 Biomaterials Market, by Type
8 Company Profiles
8.1 BASF SE
8.1.1 Company Overview
22.214.171.124 Financial Summary
8.1.3 BASF SE: SWOT Analysis
8.2 Bioactive Bone Substitutes Ltd.
8.2.1 Company Overview
8.2.2 About the Company
8.3 Berkeley Advanced Biomaterials Inc.
8.3.1 Company Overview
8.3.2 Product Portfolio
8.3.3 About the Company
8.4 Bioretec Ltd.
8.4.1 Company Overview
8.4.2 About the Company
8.5 CAM Bioceramics B.V.
8.5.1 Company Overview
8.5.2 About the Company
8.6 Carpenter Technology Corporation
8.6.1 Company Overview
8.6.2 Product Portfolio
8.6.3 Overall Financials
126.96.36.199 Financial Summary
8.6.4 SWOT Analysis
8.7 Celanese Corporation
8.7.1 Company Overview
8.7.2 Product Portfolio
188.8.131.52 Financial Summary
8.7.4 SWOT Analysis
8.8 Collagen Solutions
8.8.1 Company Overview
8.8.2 Product Portfolio
8.8.3 Overall Financials
184.108.40.206 Financial Summary
8.8.4 SWOT Analysis
8.9 Corbion N.V.
8.9.1 Company Overview
8.9.2 Overall Financials:
220.127.116.11 Financial Summary
8.9.3 SWOT Analysis
8.1 Covestro AG
8.10.1 Company Overview
8.10.2 Product Portfolio
8.10.3 Overall Financials:
18.104.22.168 Financial Summary
8.10.4 SWOT Analysis
Biomaterial is referred to any substance which is engineered to become biocompatible for its interaction with the biological systems. Biomaterials can be categorized as synthetic and natural. The synthetic materials consist of metals, polymers and ceramics, whereas natural biomaterials derived from natural sources include animal tissues or are engineered in the laboratory. Some tissues are harvested from animal sources such as cows or pigs. The interaction of these biomaterials with the human body aids in the treatment, augmentation, repairing or replacement of a tissue in the body.
The biomaterials, by type include biomaterials based on metals, polymers, ceramic, natural, inorganic glass, regenerative, radiopaque and hybrid-biomaterial combinations of biomaterials. The rapidly growing biomaterials market is driven by a number of potential applications found in the medical applications such as cardiovascular, orthopedic, ophthalmology, tissue engineering, neurological/central nervous system (CNS), dental, plastic surgery, and wound healing, among others.
The biomaterials market has developed significantly over the past decade and much has been attributed to the technological advancements in this field. The ecosystem of biomaterials market comprises of raw material suppliers, biomaterials manufacturers, regulatory body approvals, hospitals & clinics and end-use applications. The market has matured in developed regions such as North America and Europe and is gaining popularity in regions such as the Asia-Pacific, Middle East & Africa, and South America. Biomaterials are required in various application fields and consequently the growth of the market is highly dependent on the growth of those application verticals.
According to a new market research report titled ‘Global Biomaterials Market - Analysis and Forecast: 2017 to 2021’, the global biomaterials market was valued at $72.36 billion in 2016 and is expected to reach $151.65 billion by 2021, growing at a CAGR of 16.0% between 2017 and 2021. The biomaterials market is driven by a number of factors such as superior properties of biomaterials, increasing funds/aids by government for research purposes, increasing wound healing therapies and plastic surgeries, increasing aging/geriatric population, rise in prevalence of cardiovascular diseases, increasing awareness of regenerative medicine, increasing orthopedic disorders, and growing demand for implantable devices.
The biomaterials market is majorly segmented by type, application and geography. The major categories by type include metal based, polymer based, ceramic based, regenerative biomaterials, inorganic glass, radiopaque biomaterials, natural biomaterials and hybrid combinations biomaterials. The major applications include cardiovascular, orthopedic, ophthalmology, dental, wound healing, plastic surgery, neurological/central nervous system (CNS), tissue engineering and others such as drug delivery, urinary applications among others. By geography, the global biomaterials is segmented into North America, Europe, Asia-Pacific, Middle-East & Africa and Latin America. The global biomaterials market is expected to reach $151.65 billion by 2021, growing at a CAGR of 16.0% between 2017 and 2021.
The biomaterials market is driven by a number of factors such as superior properties of biomaterials, increasing funds as well as aids by government for research purposes, rise in wound healing therapies & plastic surgeries, growing geriatric population, rising prevalence of cardiovascular diseases, increasing awareness of regenerative medicine, high rate of orthopedic disorders, and growing demand for implantable devices. However, biocompatabilty issues, stringent safety regulations, and limitations of biomaterial based products are hampering the growth of the biomaterials market. Increasing obesity, introduction of biomaterials in cancer research, and rising patient awareness and improved lifestyle in growing economies such as India, China, and Brazil are expected to create opportunities in the biomaterials market.
The biomaterials market is segmented into various types, namely: metal based (such as stainless steel, cobalt-chrome alloys, titanium and titanium alloys, gold, silver, magnesium, and nitinol), polymer based (such as polypropylene, polyethylene terephthalate, polyetheretherketone, polytetrafluoroethylene, polyglycolide, silicone rubber, and PMMA, among others), ceramic based (such as calcium phosphate, zirconia, calcium sulphate, and carbon, among others), regenerative biomaterials, inorganic glass, radiopaque biomaterials, natural biomaterials (such as hyaluronic acid, collagen, gelatin, fibrin, cellulose, chitin, and silk, among others), and hybrid combinations biomaterials. Metal based biomaterials dominated the global biomaterials market with a share of approximately 24% in 2016. The market size of this segment is projected to reach $34.62 billion by 2021. Exceptionally high strength, biocompatibility and biodegradable properties allow these metals to be viably used for biomaterial applications.
The metallic biomaterials and their alloys are used majorly in load-bearing applications for which the desired properties are high strength, stiffness, corrosion resistance, fatigue strength, easy sterilization, shape memory and biocompatabilty, among others. For similar reasons, metals are the most widely used biomaterials for load-bearing implants and orthopedic surgeries involving metallic implants. Metals are used in all the applications of biomaterials such as cardiovascular, orthopedic, ophthalmology, and dental, among others. From simple wires, rods, pins, screws to fracture fixation plates and total joint prostheses (artificial joints) for hips, knees, shoulders, and ankles, among others, metals are used in all kinds of applications including maxillofacial surgery, cardiovascular surgery, dental materials etc.
On the basis of application, biomaterials market is segmented into cardiovascular, orthopedics, ophthalmology, wound healing, plastic surgery, tissue engineering, neurological/central nervous system, and others. The cardiovascular application segment dominated the biomaterials market with a market share of approximately 34% in 2016. The increasing use of biomaterials in cardiovascular applications is majorly subjected to its biocompatibility as biomaterials comes in contact blood, vascular endothelial cells, fibroblasts, and myocardium, as well as a number of other cells and a cellular matrix material.
Additionally, according to World Health Organization (WHO), in 2015, approximately 17.7 million population died from cardiovascular diseases, thereby, representing 31% of all the global deaths. The main risk factors of the cardiovascular diseases include tobacco use, diabetes, hyperlipidemia, unhealthy diet and obesity, physical inactivity, alcohol consumption, hypertension, and stroke, among others. Out of 17.7 million deaths, approximately 7.4 million people died due to coronary heart disease and 6.7 million from stroke.
On the basis of geography, North America dominated the biomaterials market. The increasing demand for surgeries such as cosmetic, and orthopedic (joint replacement) among others, in the healthcare industry is giving a much needed thrust to the biomaterials market in the North American region. Another major reason behind the growth of the biomaterials market in the North American region is that the countries such as the U.S., Canada, and Mexico have a strong support of the government in terms of grants, funds and subsidies in R&D activities. Some of the major players operating in the North American region include Royal DSM, Invibio Ltd., Carpenter Technology Corporation, CAM Bio ceramics BV, Collagen Solutions PLC, Berkeley Advanced Biomaterials, Corbion N.V., Zimmer Biomet Holdings, Inc., and Evonik Industries AG.
Some of the key players in the biomaterials market are BASF, BBS, Berkley Advanced Biomaterial Inc., Bioretec Ltd., CAM Bioceramics, Carpenter Technology Corporation, Celanese Corp., Collagen Solutions, Corbion, Covestro, Royal DSM, Evonik Industries, Invibio, Straumann, and Zimmer Biomet. These companies provide a broad product portfolio for specific needs and industrial applications. These companies are actively aiming at an increased number of agreements, partnerships, collaborations, & contracts and products to expand their operations, thereby, enhancing their share in the biomaterials market.